Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. - Wikidata - wikimedia - TriplyDB

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.

http://www.wikidata.org/entity/Q33961798

about

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages Our local experience with the surgical treatment of ampullary cancer.Gallbladder Cancer in the 21st Century.Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer Ampullary cancer: an overview Advances in chemotherapy for pancreatic cancer Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data Base.Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base.Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives.Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report.Technology insight: Photodynamic therapy for cholangiocarcinoma.A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.Systematic review: photodynamic therapy for unresectable cholangiocarcinoma.Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.Adjuvant therapy in biliary tract and gall bladder carcinomas: a review.Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)Prognostic factors in patients with middle and distal bile duct cancers.Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis.Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers Chemotherapy and targeted therapy for gall bladder cancer.Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor New insights on cholangiocarcinoma.Adjuvant therapy in pancreatic cancer.A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.Guidelines for chemotherapy of biliary tract and ampullary carcinomas Surgical strategy for bile duct cancer: Advances and current limitations.Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.Biology and management of pancreatic cancer.Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis.Surgical procedure and long-term survival of hilar cholangiocarcinoma.The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study Review article: chemotherapy for pancreatic cancer.NCCN clinical practice guidelines in oncology: hepatobiliary cancers Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III

P2860

Q21092323-8CC4829E-E46A-49D7-BAD8-B4E443125BB3 Q24814894-2BD3C15E-3F8C-45DE-90D2-FB666DEC063B Q26784174-6E296C7F-C305-4500-802C-10CB1507C2EE Q26864932-A20B9FAC-8691-4B80-894F-549F3D622E3A Q27023881-AECD08D1-B149-48EB-B651-26296512D378 Q28085711-CD2B656E-6813-4574-809B-C9657034892D Q28534611-ACEC82F8-42C9-4D8F-A25E-A38C3A659615 Q30988473-03349933-74E2-4AE4-9D52-6B7A472EFA50 Q31135072-FF1494C1-A994-4AD3-8419-3E12E09D6197 Q31156315-A1F4E824-7E6A-45E0-BB6E-9F6A34E620B4 Q33250432-E2B0FC94-35E0-4993-A820-2D81C8B68165 Q33252543-AA1F1652-AFDC-43BB-91F1-321C8B153CCA Q33360400-E3FA647A-C498-41CB-A1AF-CF0959F5AB10 Q33391003-F0484367-A18D-4477-B9C4-F3E68B4DEFF7 Q33448593-DC318589-0C0C-4998-AA63-C0CC9BEFF083 Q33506777-89EB6BAE-5696-46D5-B0BD-4622AB5535B9 Q33593250-8150C901-EEE8-4CDD-A9C2-08E7D7DCF48B Q33656703-64F00E81-3B53-49F0-9B21-C45BA1CD8EAC Q33718365-B86760ED-4BAE-4126-91D6-D0CF17577CC7 Q33757744-7FAE2976-4AAF-41B5-AD71-472428C4AAF6 Q33942354-2D6E6E82-2EDF-410E-BB35-280281A2AD4A Q33977171-CC685F1F-DF2D-48AB-9AB3-F8817C2EA8C8 Q34265846-EA7F393E-D70F-48D2-9097-2945010F30F9 Q34391135-6548DA96-5476-4A5B-B30B-DF0C8E903C9C Q34405072-88F2D182-876F-4015-B4CA-91174079A3DF Q34484245-087AA0C8-768E-435E-879E-91352D6093E2 Q34588361-B985D917-98EC-47DF-8D62-3469F077E5F4 Q34629377-C8FB7767-99D7-463E-944C-A36B39751888 Q34640123-5E0B9FC2-78B2-48C0-BF87-D1BEB1384010 Q34649019-7F8D9AB6-D0F4-4E21-88D4-7B044314FB57 Q34978321-F90B1979-7A90-41D9-BD53-A7EDF73253C5 Q35060513-9DA2CED1-5324-4A37-ACFE-6A7028DBA350 Q35078039-32D09C55-BA10-4770-B8F2-441ED6D9245A Q35094252-D2510AF3-515C-47EA-BA49-5BBD599F9BDA Q35173757-081F1A59-6A3B-483C-8395-29C8641BD7C0 Q35244211-99F53B63-4E8D-4F81-ACE2-F4B4BA97DC56 Q35477482-0D3D751B-18BA-45FD-B79E-29A4F29F93F0 Q35599597-17BECF7B-6CF1-4F1C-B329-1A9BF343C669 Q35703937-3C05954F-309D-46A2-811D-C25E26A2D2AF Q35728465-789C9BBD-BA22-4064-BD8C-C4A2CD82130C

P2860

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.

http://www.wikidata.org/entity/Q33961798

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Is postoperative adjuvant chem ...... pancreaticobiliary carcinoma.

@ast

Is postoperative adjuvant chem ...... pancreaticobiliary carcinoma.

@en

type

label

Is postoperative adjuvant chem ...... pancreaticobiliary carcinoma.

@ast

Is postoperative adjuvant chem ...... pancreaticobiliary carcinoma.

@en

prefLabel

Is postoperative adjuvant chem ...... pancreaticobiliary carcinoma.

@ast

Is postoperative adjuvant chem ...... pancreaticobiliary carcinoma.

@en

P1433

Q33961798-6D843884-FA7B-48B8-BB94-4479D7406D47

P1476

Q33961798-C286B650-3E1B-4159-97DC-8C4DA256BAF8

P2093

Q33961798-2A2F58A2-BB91-448C-AAD1-ECA18B79B58D

Q33961798-2F1E3C68-2121-4990-AF10-4610D33619FC

Q33961798-3A10FF0D-EE45-46D1-82F8-DAD39D5C2F17

Q33961798-49997E35-104D-43F1-B633-9572AA3D902E

Q33961798-765CCA0B-BB1F-40DF-A76C-0A6AF93D2E34

Q33961798-B266A2A7-7AFE-4C09-B0A0-F4B53A5500B2

Q33961798-BBC95DDD-D4EC-4AC7-B9B6-AF9435D3729D

Q33961798-D7443F46-9A22-4331-9539-91E5899B148B

Q33961798-FFF100DD-3D10-478D-BFF9-CE251C630F8D

P2860

Q33961798-013C7A7C-4682-4BD5-A892-8CE1A2F0CE1C

Q33961798-0E743E54-D066-4823-AF67-0CF9FED54950

Q33961798-0EC16B92-1D4D-4F09-882D-DFCAD103724E

Q33961798-4CD63E22-D991-4F34-BF67-FD22127924A9

Q33961798-714AFFA5-B52F-4AC3-98D6-DF7A58CC2F5D

Q33961798-757F0F21-1C71-4D97-8001-AE0B931021F7

Q33961798-7ECF5CEF-E84E-4FFF-B671-C298DCBC9F5C

Q33961798-9A3CFB6F-1729-45FA-8270-50E36720A152

Q33961798-A6F62750-D7D5-47FA-B864-C09794773A2D

Q33961798-B73FADFB-2B98-4D8B-BEFB-4CFD47389CC6

P304

Q33961798-18EBA13F-B8D0-48DD-920B-313DD01D3CBC

P31

Q33961798-DEFA3A28-E762-425E-90E5-7543AC60B090

P356

Q33961798-7C9BF16A-9368-4476-844F-C95BC5C41B6D

P407

Q33961798-1CBA0EBF-7E8A-429E-82CB-2AB7D964DAAA

P433

Q33961798-B5166A42-8738-4E08-86B3-69CCC748D3A5

P478

Q33961798-8504E07B-571B-4BC4-8C08-F4804F336330

P577

Q33961798-5C93320C-F743-4AED-9A80-23F927714E86

P5875

Q33961798-F7754E63-E643-494B-9BCA-DABE586A7008

P698

Q33961798-FC45E834-DF94-4AA0-AABD-2E57D444EBAF

P921

Q33961798-39472A4C-CDDD-4C8C-A777-D4FD99FF1F24

Q33961798-8C9E641B-55C3-4E8E-8D99-FA21EA91D543

Q33961798-9F43A333-07B9-4DE7-B1B3-7970DEDCC470

Q33961798-AA91D048-67DE-438F-84B3-896890693ACA

P356

P1433

P1476

Is postoperative adjuvant chem ...... pancreaticobiliary carcinoma.

@en

P2093

Hideki Yasuda

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kato

http://www.w3.org/2001/XMLSchema#string

Hodaka Amano

http://www.w3.org/2001/XMLSchema#string

Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract

http://www.w3.org/2001/XMLSchema#string

Tadahiro Takada

http://www.w3.org/2001/XMLSchema#string

Takashi Matsushiro

http://www.w3.org/2001/XMLSchema#string

Takukazu Nagakawa

http://www.w3.org/2001/XMLSchema#string

Toshimichi Nakayama

http://www.w3.org/2001/XMLSchema#string

Yuji Nimura

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Outcomes after curative resections of cholangiocarcinoma.

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

Adenocarcinoma of the ampulla of Vater. A 28-year experience.

Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma.

Carcinoma of the gallbladder. Does radical resection improve outcome?

Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas.

Primary carcinoma of the gallbladder. Adjuvant postoperative external irradiation.

P304

1685-1695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.10831

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264737555

http://www.w3.org/2001/XMLSchema#string

P698

12365016

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

multicenter trial